Drug intelligence / Profile preview

Rheumacon

Development stage: Unknown
Lead developer: Hahnemann Pure Drug
Administration: Oral, Topical

Overview

Rheumacon is a line of homeopathic and Ayurvedic OTC formulations developed and manufactured by Hapdco Lifesciences. Available in various dosage forms including topical oil, oral drops, and syrup, Rheumacon is designed to provide relief from acute and chronic muscular and joint pain. The formulations contain a blend of traditional homeopathic and herbal ingredients, such as *Arnica montana*, *Rhus toxicodendron*, *Gaultheria procumbens* (methyl salicylate), *Aconitum napellus*, and *Magnesium phosphoricum*. It is primarily indicated for the management of joint stiffness, arthritis, gout, osteoarthritis, lumbago, sciatica, sprains, and strains by reducing inflammation and improving local blood circulation.

Brand names: Rheumacon
Other names: ReumaconRheumacone

Beyond the preview

Go deeper on Rheumacon.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rheumacon.

Explore the full profile